N-(3-fluoro-2-methylphenyl)acetamide | 322-33-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(3-fluoro-2-methylphenyl)acetamide
• CAS: 322-33-8
• 化学式: C₉H₁₀FNO
• 分子量: 167.183
• InChiKey: DRWDVKWDDZYKLW-UHFFFAOYSA-N

物化性质

• 熔点：
  132-133°

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 海关编码：
  2924299090

反应信息

• 作为反应物：
  描述：

  N-(3-fluoro-2-methylphenyl)acetamide 在 溴 作用下， 生成 N-(4-Bromo-3-fluoro-2-methylphenyl)acetamide
  参考文献：
  名称：

  Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators

  摘要：

  Pharmacokinctic studies in cynomolgus monkeys with a novel prototype selective androgen receptor modulator revealed trace amounts of an aniline fragment released through hydrolytic metabolism. This aniline fragment was determined to be mutagenic in an Ames assay. subsequent concurrent optimization for target activity and avoidance of mutagenicity led to the identification of a pharmacologically superior clinical candidate without mutagenic potential. (c) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.01.076
• 作为产物：
  描述：

  3-氟-2-甲基苯胺 在 乙酸酐 作用下， 以 乙醇 为溶剂， 生成 N-(3-fluoro-2-methylphenyl)acetamide
  参考文献：
  名称：

  Bicyclic modulators of androgen receptor function

  摘要：

  该发明提供了符合公式I1的化合物，其中取代基如本文所述。还提供了使用这些化合物治疗核激素受体相关疾病的方法，例如与年龄相关的疾病，比如肌少症。还提供了含有这些化合物的药物组合物以及制备该发明部分化合物的方法。

  公开号：

  US20040181064A1

文献信息

• [EN] FUSED PYRIDINE AND PYRAZINE DERIVATIVES AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS CONDENSÉS DE PYRIDINE ET DE PYRAZINE EN TANT QU'INHIBITEURS DE KINASES
  申请人：UCB PHARMA SA

  公开号：WO2010092340A1

  公开（公告）日：2010-08-19

  A series of amino-substituted fused pyridine and pyrazine derivatives, in particular amino-substituted quinoline and quinoxaline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.

  一系列氨基取代的融合吡啶和吡嗪衍生物，特别是氨基取代的喹啉和喹喔啉衍生物，作为选择性PI3激酶酶抑制剂，在医学上具有益处，例如在治疗炎症性、自身免疫性、心血管、神经退行性、代谢性、肿瘤学、疼痛性或眼科疾病方面。
• Copper-(II) Catalyzed <i>N</i> -Formylation and <i>N</i> -Acylation of Aromatic, Aliphatic, and Heterocyclic Amines and a Preventive Study in the C-N Cross Coupling of Amines with Aryl Halides
  作者：Rahul B. Sonawane、Nishant K. Rasal、Dattatraya S. Bhange、Sangeeta V. Jagtap

  DOI：10.1002/cctc.201800609

  日期：2018.9.7

  A Cu‐(II) catalyzed N‐formylation and N‐acylation of amines with moderate to excellent yields, using N, N‐dimethyl formamide (DMF) and N, N‐dimethyl acetamide (DMA) as a formyl and acylating sources in the presence of 1,2,4‐triazole is reported. This novel, highly efficient and simple protocol shows broad substrate scope for aliphatic, aromatic, and heterocyclic amines. In addition, the conditions

  甲CU-（II）催化的Ñ -formylation和Ñ胺的酰化以中等至良好的产率，使用N，N-二甲基甲酰胺（DMF）和N，N-二甲基乙酰胺（DMA），为甲酰基和酰化在源据报道存在1,2,4-三唑。这种新颖，高效且简单的方案显示了脂族，芳族和杂环胺的广泛底物范围。此外，当使用DMF和DMA作为溶剂，并使用各种催化剂，配体和碱时，通常描述了防止胺和芳基卤化物的C-N交叉偶联中的N-甲酰化和N-酰化杂质的条件。
• SUBSTITUTED THIAZOLIDINEDIONE INDAZOLES, INDOLES AND BENZOTRIAZOLES AS ESTROGEN-RELATED RECEPTOR-a MODULATORS
  申请人：Bignan Gilles

  公开号：US20110294780A1

  公开（公告）日：2011-12-01

  The present invention relates to compounds of Formula (I), methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.

  本发明涉及式(I)的化合物，制备这些化合物的方法，组合物，中间体及其衍生物，并用于治疗包括但不限于强直性脊柱炎，动脉粥样硬化，关节炎（如类风湿关节炎，感染性关节炎，儿童关节炎，银屑病性关节炎，反应性关节炎），与骨相关的疾病（包括与骨形成有关的疾病），乳腺癌（包括对抗雌激素治疗无效的癌症），心血管疾病，软骨相关疾病（如软骨损伤/丧失，软骨退化以及与软骨形成有关的疾病），软骨发育不良，软骨肉瘤，慢性腰部损伤，慢性支气管炎，慢性炎症性气道疾病，慢性阻塞性肺疾病，糖尿病，能量稳态紊乱，痛风，假性痛风，脂质紊乱，代谢综合征，多发性骨髓瘤，肥胖，骨关节炎，遗传性骨发育不全，骨溶解性骨转移，软骨软化症，骨质疏松症，帕金森病，牙周病，多肌痛风，Reiter综合征，重复性应激损伤，高血糖，血糖水平升高和胰岛素抵抗等病症的方法。
• Palladium-catalyzed monoselective C–H borylation of acetanilides under acidic conditions
  作者：Bin Xiao、Yi-Ming Li、Zhao-Jing Liu、Han-Yi Yang、Yao Fu

  DOI：10.1039/c2cc31737k

  日期：——

  A practical Pd-catalyzed reaction was developed to achieve C–H activation/C–B cross-coupling of acetanilides under acidic conditions. The new reaction shows a good functional group tolerance and an exclusive mono-selectivity. This C–H borylation method may provide a generally applicable route for the conversion of C–H moieties into many other types of bonds.

  开发了一种实用的钯催化反应，以在酸性条件下实现乙酰苯胺的C–H活化/C–B交叉耦合。该新反应表现出良好的官能团耐受性和优异的单一选择性。这种C–H硼化方法可能为将C–H结构转化为多种其他类型的键提供了一种普遍适用的途径。
• Enzymatic substrates derived from phenoxazinone and their use as developer in detection of microorganisms with peptidase activity
  申请人：bioMérieux

  公开号：US07626018B2

  公开（公告）日：2009-12-01

  Novel enzymatic substrates of the general formula below: reaction media containing the same and their use for detecting and/or identifying and/or quantifying microorganisms expressing at least one peptidase activity.

  以下是通用公式的新型酶底物：包含相同的反应介质，用于检测和/或鉴定和/或定量表达至少一种肽酶活性的微生物。